A Therapeutic Strategy for Preferential Targeting of TET2-Mutant and TET Dioxygenase–Deficient Cells in Myeloid Neoplasms

TET2 is frequently mutated in myeloid neoplasms. Genetic TET2 deficiency leads to skewed myeloid differentiation and clonal expansion, but minimal residual TET activity is critical for survival of neoplastic progenitor and stem cells. Consistent with mutual exclusivity of TET2 and neomorphic IDH1/2...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Blood Cancer Discov
Autori principali: Guan, Yihong, Tiwari, Anand D., Phillips, James G., Hasipek, Metis, Grabowski, Dale R., Pagliuca, Simona, Gopal, Priyanka, Kerr, Cassandra M., Adema, Vera, Radivoyevitch, Tomas, Parker, Yvonne, Lindner, Daniel J., Meggendorfer, Manja, Abazeed, Mohamed, Sekeres, Mikkeal A., Mian, Omar Y., Haferlach, Torsten, Maciejewski, Jaroslaw P., Jha, Babal K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Association for Cancer Research 2020
Soggetti:
Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7935131/
https://ncbi.nlm.nih.gov/pubmed/33681816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2643-3230.BCD-20-0173
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi